Adverum Ebit Per Revenue from 2010 to 2024
ADVM Stock | USD 7.90 0.04 0.51% |
Ebit Per Revenue | First Reported 2010-12-31 | Previous Quarter (39.54) | Current Value (41.52) | Quarterly Volatility 63.39873829 |
Check Adverum Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adverum main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.9 M, Selling General Administrative of 31.8 M or Total Revenue of 2.8 M, as well as many exotic indicators such as Price To Sales Ratio of 23.04, Dividend Yield of 0.0 or PTB Ratio of 0.96. Adverum financial statements analysis is a perfect complement when working with Adverum Biotechnologies Valuation or Volatility modules.
Adverum | Ebit Per Revenue |
Latest Adverum Biotechnologies' Ebit Per Revenue Growth Pattern
Below is the plot of the Ebit Per Revenue of Adverum Biotechnologies over the last few years. It is Adverum Biotechnologies' Ebit Per Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adverum Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
Ebit Per Revenue | 10 Years Trend |
|
Ebit Per Revenue |
Timeline |
Adverum Ebit Per Revenue Regression Statistics
Arithmetic Mean | (56.01) | |
Coefficient Of Variation | (113.19) | |
Mean Deviation | 33.99 | |
Median | (41.52) | |
Standard Deviation | 63.40 | |
Sample Variance | 4,019 | |
Range | 267 | |
R-Value | (0.02) | |
Mean Square Error | 4,327 | |
R-Squared | 0.0003 | |
Significance | 0.95 | |
Slope | (0.24) | |
Total Sum of Squares | 56,272 |
Adverum Ebit Per Revenue History
About Adverum Biotechnologies Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Adverum Biotechnologies income statement, its balance sheet, and the statement of cash flows. Adverum Biotechnologies investors use historical funamental indicators, such as Adverum Biotechnologies's Ebit Per Revenue, to determine how well the company is positioned to perform in the future. Although Adverum Biotechnologies investors may use each financial statement separately, they are all related. The changes in Adverum Biotechnologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Adverum Biotechnologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Adverum Biotechnologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Adverum Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Ebit Per Revenue | (39.54) | (41.52) |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Adverum Biotechnologies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Adverum Biotechnologies Correlation against competitors. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Adverum Stock analysis
When running Adverum Biotechnologies' price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.60) | Revenue Per Share 0.357 | Quarterly Revenue Growth (0.70) | Return On Assets (0.32) | Return On Equity (0.88) |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.